China Pharma Holdings, Inc. received SFDA approval of a new product, Tiopronin Enteric-Coated Capsules. Tiopronin is widely given as a treatment for acute and chronic hepatitis B and to relieve drug-induced liver injury. Because Tipronin can cause stomach irritation, limiting its use, China Pharma has encased its Tiopronin capsules with an enteric coating to decrease stomach mucosal irritation. More details...

Stock Symbol: (OTCBB: CPHI)